The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol
Open accessAbstract
Sirtuins with an extended N-terminal domain (NTD), represented by yeast Sir2 and human SIRT1, harbor intrinsic mechanisms for regulation of their NAD-dependent deacetylase activities. Elucidation of the regulatory mechanisms is crucial for understanding the biological functions of sirtuins and development of potential therapeutics. In particular, SIRT1 has emerged as an attractive therapeutic target, and the search for SIRT1-activating compounds (STACs) has been actively pursued. However, the effectiveness of a class of reported STACs (represented by resveratrol) as direct SIRT1 activators is under debate due to the complication involving the use of fluorogenic substrates in in vitro assays. Future efforts of SIRT1-based therapeutics necessitate the dissection of the molecular mechanism of SIRT1 stimulation. We solved the structure of SIRT1 in complex with resveratrol and a 7-amino-4-methylcoumarin (AMC)-containing peptide. The structure reveals the presence of three resveratrol molecules, two of which mediate the interaction between the AMC peptide and the NTD of SIRT1. The two NTD-bound resveratrol molecules are principally responsible for promoting tighter binding between SIRT1 and the peptide and the stimulation of SIRT1 activity. The structural information provides valuable insights into regulation of SIRT1 activity and should benefit the development of authentic SIRT1 activators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 2×
“Sirtuins areNAD-dependent protein deacetylases catalyzing the removal of the acetyl group of an acetylated lysine residue concomitant with the cleavage of the nicotinamide group from NAD, resulting in reaction products of a deacetylated protein, nicotinamide, and a novel compound (2′-O-acetyl-ADP-ribose) (Imai et al.…”
BackgroundStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160 · cited 1×
“While Sir2 primarily deacetylates Lys16 of histone H4 (H4K16), a variety of SIRT1 substrates—including histones, p53, FOXOs, and PGC-1α—have been reported (Luo et al. 2001; Vaziri et al. 2001; Brunet et al. 2004; Motta et al. 2004; Vaquero et al. 2004; Rodgers et al. 2005).”
BackgroundhSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 2×
“Regardless of the nature of the substrates, it was found that the stimulatory effect of resveratrol requires the presence of an N-terminal domain (NTD) in addition to the catalytic domain (CD) of SIRT1 (Milne et al. 2007; Hubbard et al. 2013).”
BackgroundPhylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065 · cited 7×
“…the effectiveness of resveratrol and related compounds as direct SIRT1 activators, pointing out that the observed stimulatory effect depended on the presence of a fluorescent group in the substrates used in in vitro assays (Borra et al. 2005; Kaeberlein et al. 2005; Pacholec et al. 2010).”
BackgroundResultInfluentialThe silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., & Sternglanz, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110148297 · Cited by 970
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.031 · Cited by 916
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915 · cited 5×
“…the effectiveness of resveratrol and related compounds as direct SIRT1 activators, pointing out that the observed stimulatory effect depended on the presence of a fluorescent group in the substrates used in in vitro assays (Borra et al. 2005; Kaeberlein et al. 2005; Pacholec et al. 2010).”
BackgroundResultInfluentialSelf-citationSauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Smith, J. S., Brachmann, C. B., Celic, I., Kenna, M. A., Muhammad, S., Starai, V. J., Avalos, J. L., Escalante-Semerena, J. C., Grubmeyer, C., Wolberger, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6658 · Cited by 718
Evidence for a common mechanism of SIRT1 regulation by allosteric activators
Hubbard, B. P., Gomes, A. P., Dai, H., Li, J., Case, A. W., Considine, T., Riera, T. V., Lee, J. E., E, S. Y., Lamming, D. W., et al. (2013) · Science · doi:10.1126/science.1231097 · Cited by 561
Tanner, K. G., Landry, J., Sternglanz, R., & Denu, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250422697 · Cited by 555
Guarente, L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100831 · Cited by 510
Structure of the histone deacetylase SIRT2.
Finnin, M. S., Donigian, J. R., & Pavletich, N. P. (2001) · Nature Structural Biology · doi:10.1038/89668 · Cited by 435
Resveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426
Self-citationActive Regulator of SIRT1 Cooperates with SIRT1 and Facilitates Suppression of p53 Activity
Kim, E.-J., Kho, J.-H., Kang, M.-R., & Um, S.-J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.030 · Cited by 389
Crystal Structure of a SIR2 Homolog–NAD Complex
Min, J., Landry, J., Sternglanz, R., & Xu, R.-M. (2001) · Cell · doi:10.1016/s0092-8674(01)00317-8 · Cited by 326
Self-citationStructure and Biochemical Functions of SIRT6
Pan, P. W., Feldman, J. L., Devries, M. K., Dong, A., Edwards, A. M., & Denu, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218990 · Cited by 310
Chemistry of Gene Silencing: The Mechanism of NAD+-Dependent Deacetylation Reactions
Sauve, A. A., Celic, I., Avalos, J., Deng, H., Boeke, J. D., & Schramm, V. L. (2001) · Biochemistry · doi:10.1021/bi011858j · Cited by 300
A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol
Gertz, M., Nguyen, G. T. T., Fischer, F., Suenkel, B., Schlicker, C., Fränzel, B., Tomaschewski, J., Aladini, F., Becker, C., Wolters, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049761 · Cited by 283
Structural Basis of Inhibition of the Human NAD+-Dependent Deacetylase SIRT5 by Suramin
Schuetz, A., Min, J., Antoshenko, T., Wang, C.-L., Allali-Hassani, A., Dong, A., Loppnau, P., Vedadi, M., Bochkarev, A., Sternglanz, R., et al. (2007) · Structure · doi:10.1016/j.str.2007.02.002 · Cited by 261
Sirtuin catalysis and regulation
Feldman, J. L., Dittenhafer-Reed, K. E., & Denu, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.378877 · Cited by 248
Structural basis for sirtuin function: What we know and what we don't
Sanders, B. D., Jackson, B., & Marmorstein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.009 · Cited by 244
Tanny, J. C., & Moazed, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.415 · Cited by 243
Structure of a Sir2 Enzyme Bound to an Acetylated p53 Peptide
Avalos, J. L., Celic, I., Muhammad, S., Cosgrove, M. S., Boeke, J. D., & Wolberger, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00628-7 · Cited by 237
Small-Molecule Allosteric Activators of Sirtuins
Sinclair, D. A., & Guarente, L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134657 · Cited by 223
Zhao, X., Allison, D., Condon, B., Zhang, F., Gheyi, T., Zhang, A., Ashok, S., Russell, M., MacEwan, I., Qian, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301431y · Cited by 223
SIRT1 Activation by Small Molecules
Dai, H., Kustigian, L., Carney, D., Case, A., Considine, T., Hubbard, B. P., Perni, R. B., Riera, T. V., Szczepankiewicz, B., Vlasuk, G. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133892 · Cited by 211
Liu, B., Ghosh, S., Yang, X., Zheng, H., Liu, X., Wang, Z., Jin, G., Zheng, B., Kennedy, B. K., Suh, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.007 · Cited by 211
Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
Jin, L., Wei, W., Jiang, Y., Peng, H., Cai, J., Mao, C., Dai, H., Choy, W., Bemis, J. E., Jirousek, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014928 · Cited by 204
N-Lysine Propionylation Controls the Activity of Propionyl-CoA Synthetase
Garrity, J., Gardner, J. G., Hawse, W., Wolberger, C., & Escalante-Semerena, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704409200 · Cited by 203
Structural and Functional Analysis of Human SIRT1
Davenport, A. M., Huber, F. M., & Hoelz, A. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.009 · Cited by 179
Biochemical effects of SIRT1 activators
Baur, J. A. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.025 · Cited by 159
Chemical Activation of Sir2-Dependent Silencing by Relief of Nicotinamide Inhibition
Sauve, A. A., Moir, R. D., Schramm, V. L., & Willis, I. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.032 · Cited by 147
A continuous microplate assay for sirtuins and nicotinamide-producing enzymes
Smith, B. C., Hallows, W. C., & Denu, J. M. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.07.019 · Cited by 143
Sirt1 activation by resveratrol is substrate sequence-selective
Lakshminarasimhan, M., Rauh, D., Schutkowski, M., & Steegborn, C. (2013) · Aging · doi:10.18632/aging.100542 · Cited by 133
Peptide Switch Is Essential for Sirt1 Deacetylase Activity
Kang, H., Suh, J., Jung, Y., Jung, J., Kim, M. K., & Chung, J. H. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.038 · Cited by 117
Zhao, K., Chai, X., & Marmorstein, R. (2003) · Structure · doi:10.1016/j.str.2003.09.016 · Cited by 110
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
Bemis, J. E., Vu, C. B., Xie, R. L., Nunes, J. J., Ng, P. Y., Disch, J. S., Milne, J. C., Carney, D. P., Lynch, A. V., Jin, L., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.106 · Cited by 95
Budding Yeast Silencing Complexes and Regulation of Sir2 Activity by Protein-Protein Interactions
Tanny, J. C., Kirkpatrick, D. S., Gerber, S. A., Gygi, S. P., & Moazed, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6931-6946.2004 · Cited by 86
SIRT1 Contains N- and C-terminal Regions That Potentiate Deacetylase Activity
Pan, M., Yuan, H., Brent, M. M., Ding, E. C., & Marmorstein, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285031 · Cited by 83
Nguyen, G. T. T., Gertz, M., & Steegborn, C. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.019 · Cited by 81
Structural basis for allosteric stimulation of Sir2 activity by Sir4 binding
Hsu, H.-C., Wang, C.-L., Wang, M., Yang, N., Chen, Z., Sternglanz, R., & Xu, R.-M. (2013) · Genes & Development · doi:10.1101/gad.208140.112 · Cited by 50
Self-citation
Cited by
Pal, S., & Tyler, J. K. (2016) · Science Advances · doi:10.1126/sciadv.1600584 · Cited by 860
Sirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.004 · Cited by 463
“Cao et al. reported a ternary complex of SIRT1/FdL peptide/resveratrol using a construct SIRT1(143–512) directly linked with SIRT1(641–665) and cysteine-to-serine mutations (SIRT1-143CS: C235S, C268S, C501S and C502S) (Cao et al., 2015).”
BackgroundInfluentialRole of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
Singh, V., & Ubaid, S. (2020) · Inflammation · doi:10.1007/s10753-020-01242-9 · Cited by 427
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Weiskirchen, S., & Weiskirchen, R. (2016) · Advances in Nutrition · doi:10.3945/an.115.011627 · Cited by 306
Metadata
- Authors
- Cao, D., Wang, M., Qiu, X., Liu, D., Jiang, H., Yang, N., & Xu, R.-M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-06-15
- Volume
- 29
- Issue
- 12
- Pages
- 1316-1325
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W1862685904
- Cited by
- 258
- References
- 56
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.